MeAgain vs Gleva: The All-in-One With No Free Tier
MeAgain has the broadest feature set of any GLP-1 tracker — shots, food, side effects, weight and an AI companion — and you cannot get past onboarding without paying. What that trade looks like.
The pitch, and the catch
MeAgain is the broadest GLP-1 tracker on the market. Shots or pills, food logging, side effects, weight, progress and an AI companion, all in one place. It carries a 4.8 rating from roughly 25,000 App Store ratings, so a lot of people are getting on with it.
The thing to know before you download it is that there is no free tier. You cannot get past onboarding without paying.
That is a legitimate business model and an unusual one here — Shotsy, Glapp and GlucoPal all let you use core tracking free. It means the decision has to be made from the store listing and reviews rather than from the app, which is a meaningfully worse position to decide from.
Where breadth genuinely helps
The case for an all-in-one is real, and it is the one thing running two apps cannot solve.
If your food data is in MyFitnessPal and your dose data is in a tracker, the question that matters most — what does my intake actually do across the shot cycle — is answerable only by opening both and comparing by eye. People do that once and then stop. We make the same point in the MyFitnessPal comparison, and it is not a small gap.
Putting intake and injections on one timeline closes it. If protein on the days after a shot is your live concern — and it is a common one, covered in protein targets on GLP-1 — an all-in-one is the straightforward answer.
Where breadth costs
More surface means more logging, and more logging is the single most reliable predictor of abandonment. The tracking system that survives month three is almost always the smaller one.
So the question to ask before paying is not "would I like all of this" — everyone would — but "which of these will I still be filling in during week ten". If the honest answer is doses and symptoms, you are buying breadth you will not use, and a narrower free option will serve you better.
Data syncs to the cloud, as with most of the category.
Side by side
| MeAgain | Gleva | |
|---|---|---|
| Available | Yes | No — in development |
| Free tier | None | — |
| Breadth | Widest in category | Deliberately narrow |
| Food logging | Yes, with AI | Not planned as a diary |
| AI companion | Yes | No |
| Storage | Cloud | Local-first, planned |
Where we differ
We are building the opposite bet.
MeAgain's premise is that more of your life in one app produces a better picture. Ours is that the picture fails for a different reason — not missing data, but unread data. By month three most people have doses, side effects, weights and notes, and still cannot answer whether the nausea tracks the dose or the meals.
So we are building for interpretation over capture: fewer fields, more surfaced about what the fields already say. That is a narrower product with a sharper claim, and MeAgain has the advantage of existing.
How to choose
Choose MeAgain if you want one app for treatment and food, you will actually use the breadth, and paying up front without a trial is acceptable to you.
Choose a free core tracker if you want to try before paying. Shotsy, Glapp and GlucoPal all allow that — see the full comparison.
Wait for Gleva if your problem is interpretation rather than coverage.
MeAgain is a trademark of its respective owner. Gleva is not affiliated with, endorsed by or sponsored by it. Pricing and features change — confirm on the store listing. Nothing here is medical advice.